SCHEMBL6825898

SCHEMBL6825898

N#Cc1noc(N)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25017994 0.70
SCHEMBL21366305 0.65 MAPT (0.39)
SCHEMBL18937731 0.65
SCHEMBL387432 0.64
SCHEMBL6003977 0.64 RECQL (0.58)
SCHEMBL3526724 0.61 SMN1; SMN2 (0.48)
SCHEMBL24228128 0.61 SMN1; SMN2 (0.48)
SCHEMBL1993425 0.61 MAPK1 (0.43)
SCHEMBL10765496 0.60
SCHEMBL10741341 0.60

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250084064-A1 2-AMINO-N-HETEROARYL-NICOTINAMIDES AS NAV1.8 INHIBITORS MERCK SHARP & DOHME LLC (US) 2025-03-13 US disclosed
US-12195445-B2 2-amino-N-heteroaryl-nicotinamides as Nav1.8 inhibitors MERCK SHARP & DOHME LLC (US) 2025-01-14 US disclosed
CN-115884974-B Process for preparing alkyl 7-amino-5-methyl- [1,2,5] oxadiazolo [3,4-b ] pyridinecarboxylic acid esters 勃林格殷格翰国际有限公司 2024-09-17 CN disclosed
CN-113272293-B 2-Amino-N-heteroaryl-nicotinamide as NAV1.8 inhibitor 默沙东有限责任公司 2024-06-14 CN disclosed
EP-4153599-B1 PROCESS FOR MANUFACTURING ALKYL 7-AMINO-5-METHYL-[1,2,5]OXADIAZOLO[3,4-B]PYRIDINE-CARBOXYLATE BOEHRINGER INGELHEIM INT (DE) 2024-03-13 EP disclosed
CN-115884974-A Process for preparing alkyl 7-amino-5-methyl- [1,2,5] oxadiazolo [3,4-b ] pyridinecarboxylic acid esters 勃林格殷格翰国际有限公司 2023-03-31 CN disclosed
EP-4153599-A1 PROCESS FOR MANUFACTURING ALKYL 7-AMINO-5-METHYL-[1,2,5]OXADIAZOLO[3,4-B]PYRIDINE-CARBOXYLATE Boehringer Ingelheim International GmbH (DE) 2023-03-29 EP disclosed
US-11518771-B2 Process for manufacturing alkyl 7-amino-5-methyl-[1,2,5]oxadiazolo[3,4-b]pyridine-carboxylate BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2022-12-06 US disclosed
US-11518771-B2 Process for manufacturing alkyl 7-amino-5-methyl-[1,2,5]oxadiazolo[3,4-b]pyridine-carboxylate BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2022-12-06 US disclosed
US-20220289710-A1 2-AMINO-N-HETEROARYL-NICOTINAMIDES AS NAV1.8 INHIBITORS MERCK SHARP & DOHME LLC (US) 2022-09-15 US disclosed
US-20210363156-A1 PROCESS FOR MANUFACTURING ALKYL 7-AMINO-5-METHYL- [1,2,5]OXADIAZOLO[3,4-B]PYRIDINE-CARBOXYLATE BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2021-11-25 US disclosed
US-20210363156-A1 PROCESS FOR MANUFACTURING ALKYL 7-AMINO-5-METHYL- [1,2,5]OXADIAZOLO[3,4-B]PYRIDINE-CARBOXYLATE BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2021-11-25 US disclosed
WO-2021233882-A1 PROCESS FOR MANUFACTURING ALKYL 7-AMINO-5-METHYL-[1,2,5]OXADIAZOLO[3,4-B]PYRIDINE-CARBOXYLATE BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2021-11-25 WO disclosed
EP-3873893-A1 2-AMINO-N-HETEROARYL-NICOTINAMIDES AS NAV1.8 INHIBITORS Merck Sharp & Dohme Corp. (US) 2021-09-08 EP disclosed
CN-113272293-A 2-amino-N-heteroaryl-nicotinamide as NAV1.8 inhibitors 默沙东公司 2021-08-17 CN disclosed
US-20200140411-A1 2-AMINO-N-HETEROARYL-NICOTINAMIDES AS NAV1.8 INHIBITORS MERCK SHARP & DOHME CORP. (US) 2020-05-07 US disclosed
US-20200140411-A1 2-AMINO-N-HETEROARYL-NICOTINAMIDES AS NAV1.8 INHIBITORS MERCK SHARP & DOHME CORP. (US) 2020-05-07 US disclosed
US-6740647-B1 AMIDINES AND HYDROXYAMIDINE DERIVATIVES ABBOTT GMBH & CO., KG (DE) 2004-05-25 US disclosed
EP-1051431-A1 THROMBIN INHIBITORS BASF AKTIENGESELLSCHAFT (DE) 2000-11-15 EP disclosed
WO-1999037668-A1 THROMBIN INHIBITORS BASF AKTIENGESELLSCHAFT (DE) 1999-07-29 WO disclosed